Wellington Management Group LLP raised its holdings in Dolby Laboratories (NYSE:DLB - Free Report) by 19.4% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 320,156 shares of the electronics maker's stock after acquiring an additional 52,053 shares during the quarter. Wellington Management Group LLP owned about 0.34% of Dolby Laboratories worth $16,834,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of DLB. Fifth Third Bancorp grew its holdings in Dolby Laboratories by 34.7% during the fourth quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker's stock valued at $48,000 after purchasing an additional 192 shares during the period. Aquatic Capital Management LLC bought a new position in shares of Dolby Laboratories during the 3rd quarter worth approximately $56,000. iSAM Funds UK Ltd acquired a new stake in Dolby Laboratories in the 3rd quarter valued at $68,000. Quarry LP increased its position in shares of Dolby Laboratories by 1,486.7% in the fourth quarter. Quarry LP now owns 1,190 shares of the electronics maker's stock valued at $76,000 after acquiring an additional 1,115 shares during the last quarter. Finally, Advisory Services Network LLC acquired a new position in shares of Dolby Laboratories during the 3rd quarter worth approximately $102,000. 58.56% of the stock is currently owned by institutional investors and hedge funds.
Insiders Place Their Bets
In other Dolby Laboratories news, SVP Shriram Revankar sold 3,000 shares of the stock in a transaction that occurred on Friday, August 14th. The stock was sold at an average price of $62.71, for a total transaction of $188,130.00. Following the transaction, the senior vice president directly owned 73,274 shares in the company, valued at approximately $4,595,012.54. This represents a 3.93% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Ryan Nicholson sold 1,183 shares of the business's stock in a transaction on Tuesday, August 25th. The shares were sold at an average price of $65.28, for a total transaction of $77,226.24. Following the transaction, the chief accounting officer owned 34,453 shares in the company, valued at $2,249,091.84. The trade was a 3.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 28,889 shares of company stock worth $1,706,606. 37.93% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
Several equities research analysts recently issued reports on DLB shares. Wall Street Zen downgraded shares of Dolby Laboratories from a "buy" rating to a "hold" rating in a research note on Saturday, August 1st. Rosenblatt Securities restated a "buy" rating and issued a $85.00 price target on shares of Dolby Laboratories in a research note on Friday, August 28th. Barrington Research restated an "outperform" rating and set a $90.00 price objective on shares of Dolby Laboratories in a research note on Monday, June 15th. Finally, Weiss Ratings cut shares of Dolby Laboratories from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Thursday, August 13th. Two analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, Dolby Laboratories currently has a consensus rating of "Hold" and an average price target of $87.50.
Read Our Latest Stock Report on DLB
Dolby Laboratories Stock Down 0.2%
Shares of Dolby Laboratories stock opened at $61.81 on Monday. The stock has a market cap of $5.79 billion, a price-to-earnings ratio of 26.30 and a beta of 0.80. The company's fifty day moving average is $56.58 and its 200 day moving average is $58.27. Dolby Laboratories has a twelve month low of $48.26 and a twelve month high of $73.78.
Dolby Laboratories (NYSE:DLB - Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The electronics maker reported $0.69 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.67 by $0.02. Dolby Laboratories had a return on equity of 11.08% and a net margin of 16.70%.The company had revenue of $305.00 million during the quarter, compared to the consensus estimate of $311.96 million. During the same period last year, the company earned $0.78 earnings per share. The firm's revenue was down 3.3% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. As a group, equities analysts anticipate that Dolby Laboratories will post 3.23 earnings per share for the current fiscal year.
Dolby Laboratories announced that its board has authorized a share buyback program on Thursday, July 30th that allows the company to repurchase $350.00 million in outstanding shares. This repurchase authorization allows the electronics maker to buy up to 7% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company's board of directors believes its stock is undervalued.
Dolby Laboratories Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, August 19th. Stockholders of record on Tuesday, August 11th were given a $0.36 dividend. The ex-dividend date of this dividend was Tuesday, August 11th. This represents a $1.44 annualized dividend and a dividend yield of 2.3%. Dolby Laboratories's dividend payout ratio (DPR) is 61.28%.
Dolby Laboratories Company Profile
(
Free Report)
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company's core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby's licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Dolby Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.
While Dolby Laboratories currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.